News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jene Jill M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
4
| Jene Jill M. (Director) has filed a Form 4 on Lipocine Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.2656, valued at
$8k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| Jene Jill M. (Director) has filed a Form 4 on Lipocine Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.16, valued at
$11.6k
|
|
| 04/12/2022 |
3
| Jene Jill M. (Director) has filed a Form 3 on Lipocine Inc. |
| 04/07/2020 |
4/A
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 194,805 shares
@ $0 |
|
| 01/10/2020 |
4
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 194,805 shares
@ $0 |
|
| 04/16/2019 |
4/A
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 384,615 options to buy
@ $3.72, valued at
$1.4M
|
|
| 04/01/2019 |
4
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 377,358 options to buy
@ $3.72, valued at
$1.4M
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2018 |
3
| Jene Jill M. (VP, Business Development) has filed a Form 3 on PDL BIOPHARMA, INC. |
|
|